Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03668106
Other study ID # Hawaa-4
Secondary ID
Status Terminated
Phase Phase 2/Phase 3
First received
Last updated
Start date May 1, 2018
Est. completion date July 1, 2022

Study information

Verified date September 2022
Source Benha University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A total 180 semen samples from couples diagnosed with unexplained infertility were SDF index tested , then total 120 semen samples of patients' husbands with abnormal SDF index were randomly divided and then processed by swim up, sperm gradient centrifugation and Zeta methods. SDF and ICSI outcomes are monitored after semen processing.


Description:

A total 180 semen samples from couples diagnosed with unexplained infertility were SDF index tested , then total 120 semen samples of patients' husbands with abnormal SDF index were randomly divided and then processed by swim up (G1/ n=40), sperm gradient centrifugation (G2/ n=40) and Zeta (G3/ n=40) methods. SDF test was assessed by Halosperm kit, whereas sperm morphology was assessed by spermac stain according to strict criteria. Fertilization, division, blastulation, implantation and pregnancy rates will be tabulated and statistically tested.


Recruitment information / eligibility

Status Terminated
Enrollment 20
Est. completion date July 1, 2022
Est. primary completion date June 5, 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years to 37 Years
Eligibility Inclusion Criteria: - unexplained infertile couples for 2 years - age from 20 years old to 37 years old Exclusion Criteria: - endometriosis cases - uterine factors

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
sperm processing method
different sperm processing method for selcting most proper sperm for ICSI

Locations

Country Name City State
Egypt Ahmed Saad Banha Qalubiya

Sponsors (2)

Lead Sponsor Collaborator
Benha University Hawaa Fertility Center

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sperm DNA fragmentation measure sperm integrity by halosperm assay 30 minutes
Secondary Oocyte fertilization rate no. of oocytes fertilized /total no. of oocytes day 1
Secondary Blastulation rate no of embryos blastulated / total no. of embryos day 5
Secondary pregnancy rate no of pregnant cases\ all no. of cases 15 days
See also
  Status Clinical Trial Phase
Recruiting NCT03527043 - Impact of Escitalopram on Sperm DNA Fragmentation Phase 2
Completed NCT03085433 - Sperm Selection by Microfluidic Separation Improves Embryo Quality N/A
Completed NCT06231589 - PGT-A Evaluates Advanced Sperm Selection in Embryos From High Teratozoospermia Males N/A
Completed NCT03398317 - Sperm Selection by Either PICSI or MACS in Cases With Abnormal Sperm DNA Fragmentation Index for ICSI N/A
Recruiting NCT05508217 - Impact of Telomere Biology and Sperm DNA Fragmentation on Embryonic Development
Completed NCT05494216 - Advanced Sperm Selection Techniques and Their Contribution to Blastocyst Euploidy Rates N/A